Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000)

被引:36
作者
Arbyn, Marc [1 ,2 ]
Simoens, Cindy [1 ]
Van Oyen, Herman [3 ]
Foidart, Jean-Michel [4 ]
Goffin, Frederic [4 ]
Simon, Philippe [5 ]
Fabri, Valerie [6 ]
机构
[1] Sci Inst Publ Hlth, Canc Epidemiol Unit, Belgian Canc Ctr, B-1050 Brussels, Belgium
[2] IARC, European Network Informat Canc Epidemiol, Lyon, France
[3] Sci Inst Publ Hlth, Dept Canc Epidemiol, B-1050 Brussels, Belgium
[4] Univ Liege, Dept Gynecol & Obstet, Liege, Belgium
[5] Free Univ Brussels, Hop Erasme, Serv Gynecol Obstet, B-1070 Brussels, Belgium
[6] Intermutualist Agcy IMA AIM, Brussels, Belgium
关键词
Cervical cancer screening; Pap smear; Screening coverage; Colposcopy; Conization; Hysterectomy; Belgium; CANCER; MORTALITY; WOMEN; GUIDELINES; MANAGEMENT; PHYSICIAN; OUTCOMES;
D O I
10.1016/j.ypmed.2009.02.021
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Cervical cancer screening by surveys overestimate coverage because of selection and reporting biases. Methods. The prepared Inter-Mutualistic Agency dataset has about 13 million records from Pap smears, colposcopies, cervical biopsies and surgery, performed in Belgium between 1996 and 2000. Cervical cancer screening coverage was defined as the proportion of the target population (women of 25-64 years) that has had a Pap smear taken within the last 3 years. Proportions and incidence rates were computed using official population data of the corresponding age group, area and calendar year. Results. Cervical cancer screening coverage, in the period 1998-2000, was 59% at national level, for the target age group 25-64 years. Differences were small between the 3 regions. Variation ranged from 39% to 71%. Coverage was 64% for 25-29 year old women, 67% for those aged 30-39 years, 56% for those aged 50-54. The modal screening interval was 1 year. In the 3-year period 1998-2000, 3 million smears were taken from the 2.7 million women in the age group 25-64. Only 1.6 million women of the target group got one or more smears in that period and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman. Conclusion. Coverage reached only 59%, but the number of smears used was sufficient to cover more than 100% of the target population. Structural reduction of overuse and extension of coverage is warranted. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 39 条
[1]  
[Anonymous], EUROPEAN GUIDELINES
[2]  
[Anonymous], 2003, Off J Eur Union, V327, zetaepsiloniota, P34
[3]  
[Anonymous], EUR GUID QUAL ASS CE
[4]   Cervical cancer screening in the Flemish region (Belgium): measurement of the attendance rate by telephone interview [J].
Arbyn, M ;
Quataert, P ;
VanHal, G ;
VanOyen, H .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (04) :389-398
[5]   Cervical cancer screening in Belgium [J].
Arbyn, M ;
Van Oyen, H .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (17) :2191-2197
[6]   Burden of cervical cancer in Europe: estimates for 2004 [J].
Arbyn, M. ;
Raifu, A. O. ;
Autier, P. ;
Ferlay, J. .
ANNALS OF ONCOLOGY, 2007, 18 (10) :1708-1715
[7]   Trend of cervical cancer mortality in Belgium (1954-1994): Tentative solution for the certification problem of unspecified uterine cancer [J].
Arbyn, M ;
Geys, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (06) :649-654
[8]   Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis [J].
Arbyn, M. ;
Kyrgiou, M. ;
Simoens, C. ;
Raifu, A. O. ;
Koliopoulos, G. ;
Martin-Hirsch, P. ;
Prendiville, W. ;
Paraskevaidis, E. .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7673) :798-803
[9]  
ARBYN M, 1999, EUR J HLTH LAW, V6, P401
[10]  
ARBYN M, EUR J CANC IN PRESS